FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sirolimus submitted by Mylan Pharmaceuticals Inc., updating its regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organ Transplant Rejection

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

SUPPL AP for SIROLIMUS (SIROLIMUS)